Please sign in to follow a disease.
Back-to-Front: can a skin flap reach every upper body defect?
NCT ID NCT07734337
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial tests whether a skin flap taken from the back, called a thoracodorsal artery perforator (TDAP) flap, can reliably reach and repair soft tissue defects in the upper body. The study will enroll 20 people who need reconstruction of areas like the breast, shoulder, chest wall, or armpit after cancer surgery, trauma, or scar release. Surgeons will measure how far the flap can stretch without compromising its blood supply, aiming to determine its full range of use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a surgical procedure using a skin flap from the back (thoracodorsal artery perforator flap) to reconstruct upper body soft tissue
- What this could lead to
- If successful, this could offer a reliable, single-step surgical option for repairing complex defects in the upper body without needing microsurgery.
- What could go wrong
- This is a small, early-stage trial with only 20 participants. The flap may not always reach the intended site or could have blood supply issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 5 to 75 years old * Both sexes * Requiring upper body soft tissue reconstruction (e.g. breast, shoulder chest wall, axilla) following oncological resection, trauma, or contracture excision * Adequate general condition for surgery Exclusion Criteria: * Patients with uncontrolled comorbidities. * Prior surgery or radiation in the donor region that compromises vascular anatomy. * Active local infection or poor wound bed vascularity.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Reconstruction of upper body soft tissue defects are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sohag University
Sohag, Sohag Governorate, 82511, Egypt